HIGHLIGHTS
- who: Haibo Zhan and colleagues from the Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China have published the research work: Exosomal CTCF Confers Cisplatin Resistance in Osteosarcoma by Promoting Autophagy via the IGF2-AS/miR-579-3p/MSH6 Axis, in the Journal: Journal of Oncology of 31/05/2022
- what: The authors aim to investigate the role of cisplatin(CDDP-) resistant osteosarcoma- (OS-) derived exosomal CTCF in OS cell resistance to CDDP and its mechanistic basis. The focus of this study shifted to find the downstream genes of IGF2-AS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.